Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO)
TWD 78.5
(-29.28%)
TWD 78.5
(-29.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -46.24 Million TWD | -53.26% |
| 2022 | -30.17 Million TWD | -53.82% |
| 2021 | -19.61 Million TWD | -73.07% |
| 2020 | -11.33 Million TWD | -9.96% |
| 2019 | -10.3 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -26.04 Million TWD | -0.06% |
| 2023 FY | - TWD | -53.26% |
| 2023 Q4 | -26.02 Million TWD | -28.74% |
| 2023 Q2 | -20.21 Million TWD | -7.69% |
| 2022 Q4 | -18.77 Million TWD | 0.0% |
| 2022 FY | - TWD | -53.82% |
| 2021 FY | - TWD | -73.07% |
| 2020 FY | - TWD | -9.96% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 111.749% |
| Level Biotechnology Inc. | 98.7 Million TWD | 146.851% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -3.364% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 35.875% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -83.268% |
| GlycoNex Incorporation | -126.82 Million TWD | 63.538% |
| VBI | -6.97 Million TWD | -563.282% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 67.818% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 312.031% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -160.882% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 55.369% |
| Visgeneer Inc. | 973 Thousand TWD | 4852.724% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 86.378% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 104.938% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 146.32% |
| Neith Corporation | -33.61 Million TWD | -37.59% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 95.334% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -2562.291% |
| Enimmune corporation | -228.96 Million TWD | 79.803% |
| TaiRx, Inc. | -208.64 Million TWD | 77.836% |
| CHO Pharma, Inc. | -277.73 Million TWD | 83.349% |
| EirGenix Inc. | -664.4 Million TWD | 93.04% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 162.573% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 166.882% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 95.684% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 59.114% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 232.74% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 25.821% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -75.833% |
| RBC Bioscience Corporation | 36.54 Million TWD | 226.533% |
| BiOptic Inc. | 65.03 Million TWD | 171.103% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 93.224% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -40.108% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 15.79% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 110.666% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 42.247% |
| NaviFUS Corp. | -55.79 Million TWD | 17.118% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -178.612% |
| Sinew Pharma Inc. | -163.63 Million TWD | 71.739% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 24.807% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 124.035% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 79.599% |
| AP Biosciences Inc | -325.51 Million TWD | 85.794% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 95.573% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -29.007% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 258.75% |
| Intech Biopharm Corporation | -219.58 Million TWD | 78.94% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 93.141% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -2.876% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 71.251% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 107.055% |
| TCI GENE Inc. | 25.98 Million TWD | 277.992% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 58.202% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 83.705% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 68.32% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 433.892% |
| PharmaEngine, Inc. | 347.3 Million TWD | 113.315% |
| Savior Lifetec Corporation | 219.6 Million TWD | 121.058% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 126.85% |
| OBI Pharma, Inc. | -855.08 Million TWD | 94.592% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 50.041% |
| Acepodia, Inc. | -764.51 Million TWD | 93.951% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 89.949% |